Sale!

PT-141 10 mg

Original price was: $54.99.Current price is: $49.99.

PT-141 10 mg research-use material for qualified laboratory and non-clinical research purposes. Not intended for human or animal use. Provided as a dry lyophilized powder that needs reconstitution with suitable diluent such as bacteriostatic water, please order separately if needed

⚠ Product Usage: For Research Use Only – Not for Human or Veterinary Use

10peptides products are supplied to qualified research professionals and institutional users for in vitro laboratory research only. KYC verification is required prior to order fulfillment, and we reserve the right to refuse orders that do not meet buyer qualification criteria. These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use. Any such use is prohibited and may violate federal, state, or local law. By purchasing, the buyer represents and warrants that the product will be used solely for in vitro research.

Molecular Specifications

Molecular Data
Product Ref	PT141
CAS Number	1607799-13-2
Chemical Class	synthetic cyclic heptapeptide
Molecular Weight	1,085.22 g/mol
Sequence Length	Exactly 7 amino acids (heptapeptide)
Format	Lyophilized powder (typically solid white appearance)
Mass Format	10 mg
Purity	Greater than 99%
Solubility	Highly soluble in water, sterile saline, bacteriostatic water, and buffered aqueous solutions. Its aqueous solubility at pH 7.4 is quantified at >50 mg/mL
Storage	Store at -20°C as a dry lyophilized powder for long-term stability
Intended Use	For laboratory research use only

Product Description

PT-141 10 mg is offered by 10peptides.com as a clearly labeled research-use material for qualified laboratory and non-clinical research purposes. This product is intended for research use only and is not intended for human or animal use, consumption, diagnosis, treatment, prevention, or therapeutic application. Each vial is labeled for research use only and is available through secure online ordering with reliable customer support.

Potential Research Application

PT-141: a melanocortin agonist for the treatment of sexual dysfunction

FAQ

Is PT-141 (Bremelanotide) from 10peptides the same as the FDA-approved drug Vyleesi?

No — these are legally and materially distinct products. Vyleesi is the FDA-approved pharmaceutical product manufactured by Palatin Technologies under pharmaceutical GMP as bremelanotide acetate 1.75 mg/0.3 mL sterile subcutaneous autoinjector (NDA 210557, approved 21 June 2019). 10peptides supplies PT-141 (Bremelanotide) as a lyophilized Research Use Only (RUO) reagent governed by 21 CFR 312.2(b)(1). The RUO reagent is not a pharmaceutical product, is not FDA-approved for any application, is not compounded under 503A/503B frameworks, and is not intended for administration to living organisms. Purchase confirms agreement to institutional laboratory research use only.